Dose of imatinib mesylate patients receive oral imatinib mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

K562 Cells Philadelphia Chromosome Cell Line, Tumor Chromosomes, Human, Pair 9 Neoplastic Stem Cells Myeloid Progenitor Cells Cells, Cultured Bone Marrow Orbit Hematopoietic Stem Cells HL-60 Cells Stromal Cells Skin Fibroblasts Tumor Cells, Cultured

Organisms1

Diseases31

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Blast Crisis Hypereosinophilic Syndrome Hypopigmentation Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Dermatofibrosarcoma Mastocytosis, Systemic Fibromatosis, Aggressive Leukemia, Myeloid, Accelerated Phase Lichenoid Eruptions Neoplasm, Residual Disease Progression Primary Myelofibrosis Recurrence Scleroderma, Systemic Precursor Cell Lymphoblastic Leukemia-Lymphoma Histiocytoma, Malignant Fibrous Fibrosis Graves Ophthalmopathy Spinal Cord Neoplasms Leukemia Chromosome Aberrations Pulmonary Fibrosis Neutropenia Nerve Sheath Neoplasms Bone Neoplasms Peritoneal Neoplasms

Chemicals and Drugs43

Benzamides Piperazines Pyrimidines Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Receptor, Platelet-Derived Growth Factor beta Proto-Oncogene Proteins c-abl Protein-Tyrosine Kinases Receptors, Platelet-Derived Growth Factor Enzyme Inhibitors Pregnatrienes Thiazoles Proto-Oncogene Proteins c-sis Harringtonines Interferon-alpha mRNA Cleavage and Polyadenylation Factors Ketones Pyrroles Furans Rifabutin Hydroxyurea STAT5 Transcription Factor Platelet-Derived Growth Factor Stem Cell Factor RNA, Messenger Indoles Oncogene Proteins, Fusion Antigens, CD34 Milk Proteins Cytarabine Neoplasm Proteins src-Family Kinases P-Glycoprotein Lactams, Macrocyclic ATP-Binding Cassette Transporters Benzoquinones Ergoloid Mesylates Deferoxamine Bleomycin Pyridines

Analytical, Diagnostic and Therapeutic Techniques and Equipment28

Cytogenetic Analysis Treatment Outcome Remission Induction Drug Approval Disease-Free Survival Administration, Oral Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Survival Analysis Prognosis Treatment Failure Salvage Therapy Survival Rate Reverse Transcriptase Polymerase Chain Reaction In Situ Hybridization, Fluorescence Inhibitory Concentration 50 Follow-Up Studies Combined Modality Therapy Blood Cell Count Neoadjuvant Therapy Immunohistochemistry Transplantation, Homologous Blotting, Western Drug Screening Assays, Antitumor Hematopoietic Stem Cell Transplantation DNA Mutational Analysis Clinical Trials as Topic Positron-Emission Tomography

Phenomena and Processes20

Drug Resistance, Neoplasm Genes, abl Philadelphia Chromosome Dose-Response Relationship, Drug Apoptosis Cell Proliferation Time Factors Drug Synergism Phosphorylation Mutation Gene Expression Regulation, Leukemic Chromosomes, Human, Pair 9 Inhibitory Concentration 50 Signal Transduction Cell Survival Blood Cell Count G0 Phase Cell Division Chromosome Aberrations Gene Expression Regulation, Neoplastic

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science1

Health Care8

Treatment Outcome Disease-Free Survival Survival Analysis Treatment Failure United States Food and Drug Administration Survival Rate Follow-Up Studies Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta Blast Crisis Drug Resistance, Neoplasm Genes, abl Hypereosinophilic Syndrome Cytogenetic Analysis Proto-Oncogene Proteins c-abl Protein-Tyrosine Kinases Hypopigmentation K562 Cells Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Treatment Outcome Remission Induction Receptors, Platelet-Derived Growth Factor Dermatofibrosarcoma Mastocytosis, Systemic Drug Approval Enzyme Inhibitors Pregnatrienes Cell Line, Tumor Thiazoles Fibromatosis, Aggressive Dose-Response Relationship, Drug Proto-Oncogene Proteins c-sis Disease-Free Survival Harringtonines Leukemia, Myeloid, Accelerated Phase Administration, Oral Apoptosis Cell Proliferation Interferon-alpha Lichenoid Eruptions Time Factors Drug Administration Schedule mRNA Cleavage and Polyadenylation Factors Drug Synergism Phosphorylation Neoplasm, Residual Mutation Antineoplastic Combined Chemotherapy Protocols Ketones Survival Analysis Pyrroles Furans Gene Expression Regulation, Leukemic Cytogenetics Prognosis Treatment Failure United States Food and Drug Administration Rifabutin Salvage Therapy Disease Progression Primary Myelofibrosis Chromosomes, Human, Pair 9 Survival Rate Reverse Transcriptase Polymerase Chain Reaction Hydroxyurea In Situ Hybridization, Fluorescence Neoplastic Stem Cells STAT5 Transcription Factor Platelet-Derived Growth Factor Recurrence Scleroderma, Systemic Precursor Cell Lymphoblastic Leukemia-Lymphoma Stem Cell Factor Histiocytoma, Malignant Fibrous Inhibitory Concentration 50 Follow-Up Studies Signal Transduction RNA, Messenger Myeloid Progenitor Cells Indoles Cell Survival Fibrosis Combined Modality Therapy Blood Cell Count Neoadjuvant Therapy Immunohistochemistry Graves Ophthalmopathy Oncogene Proteins, Fusion Cells, Cultured Antigens, CD34 Bone Marrow Transplantation, Homologous Milk Proteins Blotting, Western Orbit

No FAQ available that match "dose of imatinib mesylate patients receive oral imatinib mesylate"